Stanford Team Develops Non-invasive, DNA-based Transplant Rejection Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Stanford University researchers have developed a non-invasive, sequencing-based strategy for gauging rejection in organ transplant recipients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.